These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10398626)

  • 21. Placebo cure rates in the treatment of onychomycosis.
    Gupta AK; Paquet M
    J Am Podiatr Med Assoc; 2014 May; 104(3):277-82. PubMed ID: 24901587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.
    Gupta AK; Leonardi C; Stoltz RR; Pierce PF; Conetta B;
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):437-43. PubMed ID: 15987289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are placebo-controlled trials of creams for athlete's foot still justified?
    Crawford F; Harris R; Williams HC
    Br J Dermatol; 2008 Sep; 159(4):773-9. PubMed ID: 18834482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview of topical antifungal therapy in dermatomycoses. A North American perspective.
    Gupta AK; Einarson TR; Summerbell RC; Shear NH
    Drugs; 1998 May; 55(5):645-74. PubMed ID: 9585862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fungal infections of skin and nails of feet. Pragmatic clinical trial is now needed.
    Williams H
    BMJ; 1999 Oct; 319(7216):1070-1. PubMed ID: 10521215
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of systemic antimycotics in dermatotherapy.
    Niewerth M; Korting HC
    Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advancements in Topical Antifungal Vehicles.
    Kircik LH
    J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s44-8. PubMed ID: 26885798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Gupta AK; Elewski BE; Sugarman JL; Ieda C; Kawabata H; Kang R; Pillai R; Olin JT; Watanabe S
    J Drugs Dermatol; 2014 Jul; 13(7):815-20. PubMed ID: 25007364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical therapy for toenail onychomycosis: an evidence-based review.
    Gupta AK; Daigle D; Foley KA
    Am J Clin Dermatol; 2014 Dec; 15(6):489-502. PubMed ID: 25257931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onychomycosis does not always require systemic treatment for cure: a trial using topical therapy.
    Friedlander SF; Chan YC; Chan YH; Eichenfield LF
    Pediatr Dermatol; 2013; 30(3):316-22. PubMed ID: 23278851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fungal infections of skin and nails of feet. Authors of meta-analysis defend their view.
    Hart R; Bell-Syer SE; Crawford F; Young P; Russell I; Torgerson DJ
    BMJ; 1999 Oct; 319(7216):1070. PubMed ID: 10576854
    [No Abstract]   [Full Text] [Related]  

  • 32. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR; Scher RK
    Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onychomycosis: burden of disease and the role of topical antifungal treatment.
    Daniel RC
    J Drugs Dermatol; 2013 Nov; 12(11):1263-6. PubMed ID: 24196334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients.
    Cook-Bolden FE; Lin T
    Cutis; 2017 Apr; 99(4):286-289. PubMed ID: 28492600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails.
    Roberts DT
    Dermatology; 1997; 194 Suppl 1():37-9. PubMed ID: 9154400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tavaborole - a treatment for onychomycosis of the toenails.
    Gupta AK; Versteeg SG
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1145-52. PubMed ID: 27347905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.
    Vardakas KZ; Samonis G; Michalopoulos A; Soteriades ES; Falagas ME
    Crit Care Med; 2006 Apr; 34(4):1216-24. PubMed ID: 16484923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodynamic therapy treatment of superficial fungal infections: A systematic review.
    Shen JJ; Jemec GBE; Arendrup MC; Saunte DML
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101774. PubMed ID: 32339671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical and physical strategies in onychomycosis topical treatment: A review.
    Angelo T; Borgheti-Cardoso LN; Gelfuso GM; Taveira SF; Gratieri T
    Med Mycol; 2017 Jul; 55(5):461-475. PubMed ID: 27703019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.